公开(公告)号：US20230355180A1

公开(公告)日：2023-11-09

申请号：US17805839

申请日：2022-06-07

申请人： HDL Therapeutics, Inc.

发明人： Hollis Bryan Brewer, JR. ,  Michael M. Matin

IPC分类号： A61B5/00 ,  A61M1/00 ,  A61K35/14 ,  A61M1/02 ,  A61M1/36 ,  A61B5/02 ,  A61F2/82 ,  A61L31/16

CPC分类号： A61B5/6866 ,  A61M1/00 ,  A61K35/14 ,  A61M1/0281 ,  A61M1/3687 ,  A61M1/3607 ,  A61B5/02007 ,  A61F2/82 ,  A61L31/16 ,  A61M2202/0458 ,  A61M2202/0456 ,  A61L31/10

摘要： The present specification is directed to systems, apparatus and methods for treating lipid-related diseases including homozygous familial hypercholesterolemia, heterozygous familial hypercholesterolemia, ischemic stroke, coronary artery disease, acute coronary syndrome, peripheral arterial disease, or renal arterial disease and its complications, and for treating the progression of Alzheimer's disease using imaging techniques to assess changes in one or more lipid-containing atheroma areas and volumes after serial infusions of delipidated plasma as compared to a baseline